Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL7619712 | 1.00 | CHRM1 (0.79) | CHRM1CHRM4 | |
| SCHEMBL6913833 | 0.95 | CHRM1 (0.88) | CHRM1CHRM4 | |
| SCHEMBL7613052 | 0.95 | CHRM1 (0.88) | CHRM1CHRM4 | |
| Tazomeline SCHEMBL7615741 | 0.92 | CHRM1 (0.79) | CHRM1CHRM4 | |
| Oxalic Acid SCHEMBL7642910 | 0.92 | CHRM1 (0.79) | CHRM1CHRM4 | |
| Oxalic Acid SCHEMBL7619270 | 0.92 | CHRM1 (0.79) | CHRM1CHRM4 | |
| Oxalic Acid SCHEMBL7613481 | 0.91 | CHRM1 (0.78) | CHRM1CHRM4 | |
| Oxalic Acid SCHEMBL7612725 | 0.91 | CHRM1 (0.78) | CHRM1CHRM4 | |
| Oxalic Acid SCHEMBL7617644 | 0.91 | CHRM1 (0.78) | CHRM1CHRM4 | |
| Oxalic Acid SCHEMBL7617251 | 0.91 | CHRM1 (0.78) | CHRM1CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0734259-B1 | Use of piperidine compounds in the treatment of schizophrenia | NOVO NORDISK AS (DK) | 2002-06-12 | — | — | EP | disclosed |
| US-RE36375-E | Treatment of Alzheimer's disease using azacyclic compounds | NOVO NORDISK A/S (DK) | 1999-11-02 | — | — | US | disclosed |
| US-5919805-A | 3-OXY- OR THIO-DERIVATIVES OF 1,2,5-OXADIAZOLES OR 1,2,5-THIADIAZOLES; TREATMENT OF ALZHEIMER'S DISEASE, SEVERE PAINFUL CONDITIONS AND GLAUCOMA. | NOVO NORDISK A/S (DK) | 1999-07-06 | — | — | US | disclosed |
| US-5773452-A | ALZHEIMER'S DISEASE; COGNITION ACTIVATORS | NOVO NORDISK ALS (DK) | 1998-06-30 | — | — | US | disclosed |
| US-RE35822-E | COGNITION ACTIVATORS | NOVO NORDISK A/S (DK) | 1998-06-09 | — | — | US | disclosed |
| US-5753683-A | SCHIZOPHRENIA | NOVO NORDISK A/S (DK) | 1998-05-19 | — | — | US | disclosed |
| US-5750541-A | 3-(1,2,5-THIA OR OXADIAZOL-3-YL)-1,2,5,6-PYRIDINE DERIVATIVES; SCHIZOPHRENIFORM DISEASES; SIDE EFFECT REDUCTION | NOVO NORDISK A/S (DK) | 1998-05-12 | — | — | US | disclosed |
| US-5744489-A | ADMINISTERING CERTAIN 1,2,5-THIADIAZOLE AND 1,2,5-OXADIAZOLE COMPOUNDS | GREENWOOD BEVERLEY (US) | 1998-04-28 | — | — | US | disclosed |
| EP-0544756-B1 | 1,2,5,6-TETRAHYDRO-1-METHYLPYRIDINES, THEIR PREPARATION AND USE | NOVO NORDISK AS (DK) | 1997-11-05 | — | — | EP | disclosed |
| US-5658932-A | AZACYCLIC COMPOUNDS; COGNITIVE FUNCTION STIMULANTS; ALZHEIMER'S DISEASE | NOVO NORDISK A/S (DK) | 1997-08-19 | — | — | US | disclosed |
| US-5571826-A | 1,2,5-THIADIAZOLE OR 1,2,5-OXADIAZOLE AS ANALGESICS | NOVO NORDISK A/S (DK) | 1996-11-05 | — | — | US | disclosed |
| US-5565475-A | Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives | MUHLHAUSER MARK A (US) | 1996-10-15 | — | — | US | disclosed |
| EP-0732925-A1 | A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS | NOVO NORDISK A/S (DK) | 1996-09-25 | — | — | EP | disclosed |
| US-5559136-A | Treatment of Alzheimer's disease using azacyclic compounds | NOVO NORDISK A/S (DK) | 1996-09-24 | — | — | US | disclosed |
| US-5545638-A | USING A 3-(TETRAHYDROPYRID-3-YL-) SUBSTITUTED (OXA- OR THIA-)DIAZOLE COMPOUND | NOVO NORDISK A/S (DK) | 1996-08-13 | — | — | US | disclosed |
| US-5534528-A | VISION DEFECTS | NOVO NORDISK A/S (DK) | 1996-07-09 | — | — | US | disclosed |
| WO-1995017185-A1 | A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS | NOVO NORDISK A/S (DK) | 1995-06-29 | — | — | WO | disclosed |
| US-5376668-A | Cholinergic agents as cognition activators in treatment of Alzheimer*s disease | NOVO NORDISK A/S (DK) | 1994-12-27 | — | — | US | disclosed |
| US-5328924-A | Thiadiazole hydropyridines as cognition activators for Alzheimer*s disease | NOVO NORDISK A/S (DK) | 1994-07-12 | — | — | US | disclosed |